T he new vaccines that protect older adults against respiratory syncytial virus, or RSV, may be linked to a small increased risk of developing Guillain-Barré syndrome, new data from the Centers ...

BRISBANE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...

Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease ...

Mumbai reported first case of Guillain-Barré Syndrome (GBS) in 2025 on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder, civic officials said. GBS is a rare condition ...

He sees this moment as a promising one when there is potential to make advances in the treatment of GBS after decades without any significant developments. “GBS is an acute debilitating neuromuscular ...

Mumbai, Feb. 13 -- The toll in the incidence of Guillain-Barre Syndrome (GBS) -- an autoimmune disorder where the body's immune system attacks the nervous system- rose to eight in Maharashtra on ...

SHREVEPORT, La. - In 2011, Shane Sumlin's life changed overnight after being diagnosed with a rare neurological disorder called Guillain-Barre syndrome (GBS). It causes the body to attack its own ...